An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder
Condition(s):Anxiety DisordersLast Updated:March 12, 2009Terminated
Hide Studies Not Open or Pending
Condition(s):Anxiety DisordersLast Updated:March 12, 2009Terminated
Condition(s):SchizophreniaLast Updated:February 1, 2022Unknown status
Condition(s):Periodontitis; Alzheimer DiseaseLast Updated:January 12, 2024Recruiting
Condition(s):Alzheimer Disease; Dementia; Alzheimer’s Type (Etiology); Fall Risk; Elderly; Resistance TrainingLast Updated:March 7, 2022Completed
Condition(s):Major Neurocognitive DisorderLast Updated:August 18, 2023Recruiting
Condition(s):Diabetes Mellitus; Cellular Senescence; Sodium-Glucose Transporter 2 InhibitorsLast Updated:August 4, 2023Not yet recruiting
Condition(s):Major Depression DisorderLast Updated:August 10, 2017Completed
Condition(s):Depressive Disorder, MajorLast Updated:September 2, 2013Completed
Condition(s):PNDLast Updated:April 28, 2022Recruiting
Condition(s):COPD (Chronic Obstructive Pulmonary Disease)Last Updated:April 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.